Middle East and North Africa: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Middle East and North Africa

In 2021, the MENA's human and animal blood market decreased by -X% to $X, falling for the second consecutive year after five years of growth. Over the period under review, consumption enjoyed a buoyant expansion. Over the period under review, the market hit record highs at $X in 2019; however, from 2020 to 2021, consumption failed to regain momentum.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Middle East and North Africa

In value terms, human and animal blood production reduced to $X in 2021 estimated in export price. Over the period under review, production, however, posted a strong increase. The growth pace was the most rapid in 2016 with an increase of X% against the previous year. The level of production peaked at $X in 2020, and then declined modestly in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in Middle East and North Africa

In 2021, after two years of decline, there was significant growth in overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, when their volume increased by X% to X tons. Over the period under review, exports continue to indicate a prominent expansion. Over the period under review, the exports attained the maximum at X tons in 2018; however, from 2019 to 2021, the exports failed to regain momentum.

In value terms, human and animal blood exports soared to $X in 2021. In general, exports enjoyed a buoyant increase. Over the period under review, the exports reached the peak figure at $X in 2018; however, from 2019 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Turkey represented the main exporter of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Middle East and North Africa, with the volume of exports finishing at X tons, which was near X% of total exports in 2021. Jordan (X tons) took the second position in the ranking, distantly followed by Iran (X tons). All these countries together held near X% share of total exports. The United Arab Emirates (X tons) took a relatively small share of total exports.

From 2012 to 2021, the biggest increases were in Iran (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest human and animal blood supplying countries in Middle East and North Africa were Turkey ($X), Jordan ($X) and the United Arab Emirates ($X), together comprising X% of total exports. These countries were followed by Iran, which accounted for a further X the main exporting countries, Iran, with a CAGR of +X%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the export price in Middle East and North Africa amounted to $X per ton, dropping by -X% against the previous year. In general, the export price continues to indicate a deep setback. The growth pace was the most rapid in 2017 an increase of X%. The level of export peaked at $X per ton in 2018; however, from 2019 to 2021, the export prices remained at a lower figure.

Prices varied noticeably by the country of origin: the country with the highest price was the United Arab Emirates ($X per ton), while Iran ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United Arab Emirates (+X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in Middle East and North Africa

In 2021, the amount of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imported in Middle East and North Africa surged to X tons, picking up by X% compared with 2020. Over the period under review, imports posted strong growth. The most prominent rate of growth was recorded in 2017 when imports increased by X%. The volume of import peaked at X tons in 2019; however, from 2020 to 2021, imports stood at a somewhat lower figure.

In value terms, human and animal blood imports surged to $X in 2021. Overall, imports continue to indicate a buoyant increase. The most prominent rate of growth was recorded in 2017 when imports increased by X% against the previous year. Over the period under review, imports attained the peak figure at $X in 2019; however, from 2020 to 2021, imports remained at a lower figure.

Imports by Country

Saudi Arabia represented the key importer of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Middle East and North Africa, with the volume of imports amounting to X tons, which was approx. X% of total imports in 2021. Turkey (X tons) ranks second in terms of the total imports with a X% share, followed by the United Arab Emirates (X%), Egypt (X%) and Israel (X%). Iran (X tons), Algeria (X tons) and Iraq (X tons) took a minor share of total imports.

Saudi Arabia was also the fastest-growing in terms of the human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imports, with a CAGR of +X% from 2012 to 2021. At the same time, Egypt (+X%), the United Arab Emirates (+X%), Turkey (+X%), Israel (+X%), Iran (+X%), Iraq (+X%) and Algeria (+X%) displayed positive paces of growth. While the share of Saudi Arabia (+X p.p.) and Egypt (+X p.p.) increased significantly in terms of the total imports from 2012-2021, the share of Iran (-X p.p.), Iraq (-X p.p.) and Algeria (-X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Saudi Arabia ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Middle East and North Africa, comprising X% of total imports. The second position in the ranking was taken by Turkey ($X), with a X% share of total imports. It was followed by Israel, with an X% share.

In Saudi Arabia, human and animal blood imports increased at an average annual rate of +X% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Turkey (+X% per year) and Israel (+X% per year).

Import Prices by Country

The import price in Middle East and North Africa stood at $X per ton in 2021, waning by -X% against the previous year. Overall, the import price recorded a mild shrinkage. The pace of growth appeared the most rapid in 2020 when the import price increased by X%. As a result, import price reached the peak level of $X per ton, and then fell remarkably in the following year.

Prices varied noticeably by the country of destination: the country with the highest price was Iran ($X per ton), while Egypt ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Israel (+X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform